Latest & greatest articles for Intrauterine Device

The Trip Database is a leading resource to help health professionals find trustworthy answers to their clinical questions. Users can access the latest research evidence and guidance to answer their clinical questions. We have a large collection of systematic reviews, clinical guidelines, regulatory guidance, clinical trials and many other forms of evidence. If you wanted the latest trusted evidence on Intrauterine Device or other clinical topics then use Trip today.

This page lists the very latest high quality evidence on Intrauterine Device and also the most popular articles. Popularity measured by the number of times the articles have been clicked on by fellow users in the last twelve months.

What is Trip?

Trip is a clinical search engine designed to allow users to quickly and easily find and use high-quality research evidence to support their practice and/or care.

Trip has been online since 1997 and in that time has developed into the internet’s premier source of evidence-based content. Our motto is ‘Find evidence fast’ and this is something we aim to deliver for every single search.

As well as research evidence we also allow clinicians to search across other content types including images, videos, patient information leaflets, educational courses and news.

For further information on Trip click on any of the questions/sections on the left-hand side of this page. But if you still have questions please contact us via jon.brassey@tripdatabase.com

Top results for Intrauterine Device

1. Routine Pathology for Intrauterine Devices and Therapeutic Abortion: A Review of Clinical Effectiveness, Cost-Effectiveness, and Guidelines

Routine Pathology for Intrauterine Devices and Therapeutic Abortion: A Review of Clinical Effectiveness, Cost-Effectiveness, and Guidelines Routine Pathology for Intrauterine Devices and Therapeutic Abortion: A Review of Clinical Effectiveness, Cost-Effectiveness, and Guidelines | CADTH.ca Find the information you need Routine Pathology for Intrauterine Devices and Therapeutic Abortion: A Review of Clinical Effectiveness, Cost-Effectiveness, and Guidelines Routine Pathology for Intrauterine (...) Devices and Therapeutic Abortion: A Review of Clinical Effectiveness, Cost-Effectiveness, and Guidelines Last updated: September 12, 2019 Project Number: RC1176-000 Product Line: Research Type: Devices and Systems Report Type: Summary with Critical Appraisal Result type: Report Question What is the clinical utility of routine pathology for removed intrauterine devices? What is the clinical utility of routine pathology for therapeutic abortions? What is the cost-effectiveness of routine pathology

2019 Canadian Agency for Drugs and Technologies in Health - Rapid Review

2. HIV incidence among women using intramuscular depot medroxyprogesterone acetate, a copper intrauterine device, or a levonorgestrel implant for contraception: a randomised, multicentre, open-label trial. Full Text available with Trip Pro

HIV incidence among women using intramuscular depot medroxyprogesterone acetate, a copper intrauterine device, or a levonorgestrel implant for contraception: a randomised, multicentre, open-label trial. Observational and laboratory studies suggest that some hormonal contraceptive methods, particularly intramuscular depot medroxyprogesterone acetate (DMPA-IM), might increase women's susceptibility to HIV acquisition. We aimed to compare DMPA-IM, a copper intrauterine device (IUD (...) ), and a levonorgestrel (LNG) implant among African women seeking effective contraception and living in areas of high HIV incidence.We did a randomised, multicentre, open-label trial across 12 research sites in eSwatini, Kenya, South Africa, and Zambia. We included HIV-seronegative women aged 16-35 years who were seeking effective contraception, had no medical contraindications to the trial contraceptive methods, agreed to use the assigned method for 18 months, and reported not using injectable, intrauterine

2019 Lancet Controlled trial quality: predicted high

3. Self-administered vaginal lidocaine gel for pain management with intrauterine device insertion: a blinded, randomized controlled trial Full Text available with Trip Pro

Self-administered vaginal lidocaine gel for pain management with intrauterine device insertion: a blinded, randomized controlled trial A major barrier to intrauterine device use is fear of pain during insertion. Trials exploring analgesic interventions for intrauterine device insertion have yielded mixed results, and no standardized pain management guidelines currently exist for this procedure. In an abortion-related study, self-administered lidocaine gel over a prolonged time interval showed (...) promise as a method of pain control.The objective of the study was to assess pain control with intrauterine device insertion after patient-administered lidocaine gel compared with placebo.We conducted a randomized, blinded trial of women undergoing levonorgestrel or copper intrauterine device insertion in an outpatient gynecology clinic between July 2016 and April 2017. Participants self-administered either 20 mL of 2% lidocaine gel or placebo gel vaginally at least 15 minutes prior to intrauterine

2019 EvidenceUpdates

4. Effect of topical glyceryl trinitrate cream on pain perception during intrauterine device insertion in multiparous women: A randomized double-blinded placebo-controlled study. (Abstract)

Effect of topical glyceryl trinitrate cream on pain perception during intrauterine device insertion in multiparous women: A randomized double-blinded placebo-controlled study. Intrauterine contraceptive device (IUD) insertion-related pain presents a push beyond the decline of women to use IUD for family planning. We aimed to investigate the analgesic effect of glyceryl trinitrate cream (GTN) in reducing pain during IUD insertion.We conducted a randomized double-blinded placebo-controlled study

2019 Journal of gynecology obstetrics and human reproduction Controlled trial quality: predicted high

5. A prospective, randomized study evaluating the pain felt during intrauterine device insertion by the direct technique vs conventional technique. (Abstract)

A prospective, randomized study evaluating the pain felt during intrauterine device insertion by the direct technique vs conventional technique. To assess the value of the direct insertion technique compared to the conventional insertion technique in reducing the pain experienced during placement of an intrauterine device (IUD).A prospective, controlled, randomized, single-blind trial was conducted in women eligible for IUD insertion. Participants were randomized into two groups: "conventional

2019 Journal of gynecology obstetrics and human reproduction Controlled trial quality: uncertain

6. Paracervical Block for Intrauterine Device Placement Among Nulliparous Women: A Randomized Controlled Trial Full Text available with Trip Pro

Paracervical Block for Intrauterine Device Placement Among Nulliparous Women: A Randomized Controlled Trial To investigate whether a 20-mL buffered 1% lidocaine paracervical block decreases pain during intrauterine device (IUD) placement.In a randomized, single-blind, placebo-controlled trial, women were assigned to receive either a 20-mL buffered 1% lidocaine paracervical block or no block before IUD placement. The primary outcome was pain with IUD placement measured on a 100-mm visual analog

2018 EvidenceUpdates

7. Adolescents and Long-Acting Reversible Contraception: Implants and Intrauterine Devices

Adolescents and Long-Acting Reversible Contraception: Implants and Intrauterine Devices e130 VOL. 131, NO. 5, MAY 2018 OBSTETRICS & GYNECOLOGY Adolescents and Long-Acting Reversible Contraception: Implants and Intrauterine Devices ABSTRACT: The phenomenon of adolescent childbearing is complex and far reaching, affecting not only the adolescents but also their children and their community. The prevalence and public health effect of adolescent pregnancy reflect complex structural social problems (...) and an unmet need for acceptable and effective contra- ceptive methods in this population. In 2006–2010, 82% of adolescents at risk of unintended pregnancy were currently using contraception, but only 59% used a highly effective method, including any hormonal method or intrauterine device. Long-acting reversible contraceptives (LARC) have higher efficacy, higher continuation rates, and higher satisfaction rates compared with short-acting contraceptives among adolescents who choose to use them

2018 American College of Obstetricians and Gynecologists

8. Immediate postpartum levonorgestrel intrauterine device insertion and breast-feeding outcomes: a noninferiority randomized controlled trial Full Text available with Trip Pro

Immediate postpartum levonorgestrel intrauterine device insertion and breast-feeding outcomes: a noninferiority randomized controlled trial Immediate postpartum levonorgestrel intrauterine device insertion is increasing in frequency in the United States, but few studies have investigated the effect of early placement on breast-feeding outcomes.This study examined the effect of immediate vs delayed postpartum levonorgestrel intrauterine device insertion on breast-feeding outcomes.We conducted (...) this noninferiority randomized controlled trial at the University of Utah and the University of New Mexico Health Sciences Centers from February 2014 through March 2016. Eligible women were pregnant and planned to breast-feed, spoke English or Spanish, were aged 18-40 years, and desired a levonorgestrel intrauterine device. Enrolled women were randomized 1:1 to immediate postpartum insertion or delayed insertion at 4-12 weeks' postpartum. Prespecified exclusion criteria included delivery <37.0 weeks' gestational

2018 EvidenceUpdates

9. Reducing Pain During Intrauterine Device Insertion: A Randomized Controlled Trial in Adolescents and Young Women (Abstract)

Reducing Pain During Intrauterine Device Insertion: A Randomized Controlled Trial in Adolescents and Young Women To estimate the effect of a 1% lidocaine paracervical nerve block on pain during intrauterine device (IUD) insertion compared with a sham block in adolescents and young women.We conducted a multisite, single-blind, sham-controlled randomized trial in adolescents and young women having a 13.5-mg levonorgestrel IUD inserted. Enrollment occurred at three family planning clinics

2017 EvidenceUpdates

10. Endoscopic Treatment of Intrauterine Device Migration into the Bladder with Stone Formation Full Text available with Trip Pro

Endoscopic Treatment of Intrauterine Device Migration into the Bladder with Stone Formation Background: An intrauterine device is commonly used for contraception globally. Although intrauterine device placement is an effective and safe method of contraception, migration into the bladder with stone formation is a rare and serious complication. The management approaches for an intrauterine device embedded in the bladder include endoscopic procedures and open surgical removal. In this study, we (...) report the case of a patient with recurrent urinary tract infection associated with intrauterine device migration and urolithiasis, who successfully underwent endoscopic treatment combined with laser fragmentation. Case Presentation: A 22-year-old woman presented to our hospital with a 1-month history of lower abdominal pain, hematuria, and pain on urination. Transvaginal ultrasound showed a hyperechoic lesion in the bladder. A plain abdominal radiograph showed the presence of a T-shaped intrauterine

2017 Journal of endourology case reports

11. Intrauterine Devices and Magnetic Resonance Imaging: Safety

Intrauterine Devices and Magnetic Resonance Imaging: Safety Intrauterine Devices and Magnetic Resonance Imaging: Safety | CADTH.ca Find the information you need Intrauterine Devices and Magnetic Resonance Imaging: Safety Intrauterine Devices and Magnetic Resonance Imaging: Safety Published on: March 28, 2017 Project Number: RB1074-000 Product Line: Research Type: Devices and Systems Report Type: Summary of Abstracts Result type: Report Question What is the clinical evidence regarding the safety (...) of patients with intrauterine devices using magnetic resonance imaging? Key Message No relevant literature was identified regarding the safety of patients with intrauterine devices using magnetic resonance imaging. Tags copper, intrauterine devices, intrauterine devices, copper, magnetic resonance imaging, imaging, IUD, Intrauterine, metal, Adverse, safe, MRI, MRIs, Magnetic resonance imaging Files Rapid Response Summary of Abstracts Published : March 28, 2017 Related Content Follow us: © 2019 Canadian

2017 Canadian Agency for Drugs and Technologies in Health - Rapid Review

13. Postplacental insertion of intrauterine devices

Postplacental insertion of intrauterine devices Review article Society of Family Planning Guidelines: Postplacental insertion of intrauterine devices Amy K. Whitaker a, ? , Beatrice A. Chen b a Department of Obstetrics and Gynecology, The University of Chicago, 5842 S. Maryland Ave, Chicago, IL 60637, USA b Department of Obstetrics, Gynecology and Reproductive Sciences, University of Pittsburgh School of Medicine, 300 Halket Street, Pittsburgh, PA 15213, USA Received 3 June 2017; revised 27 (...) for the postpartum visit are most likely to benefit from provision of postplacental IUD placement with appropriate counseling about risks and benefits. © 2017 Elsevier Inc. All rights reserved. Keywords: Postpartum contraception; Intrauterine device; Intrauterine system; Contraception; Levonorgestrel; Postplacental IUD; Postpartum IUD; IUD expulsion 1. Background Intrauterine device (IUD) placement within 10 min after delivery of the placenta is an appealing strategy for increasing access to postpartum IUDs

2017 Society of Family Planning

14. Use of intrauterine devices in nulliparous women

Use of intrauterine devices in nulliparous women Clinical Guidelines Use of intrauterine devices in nulliparous women Patricia A. Lohr a, ? , Richard Lyus b , Sarah Prager c a British Pregnancy Advisory Service, 20 Timothy's Bridge Road, Stratford Enterprise Park, Stratford on Avon, Warwickshire, CV37 9BF b Homerton University Hospital, London c University of Washington Received 18 August 2017; accepted 23 August 2017 Abstract Five intrauterine devices (IUDs) are available in the United States (...) : four levonorgestrel-releasing intrauterine systems (two containing 52 mg, one containing 19.5 mg and one containing 13.5 mg) and one copper-bearing device (Copper T 380A). All IUDs have very low typical- use failure rates and high acceptability ratings, yet they are used by a minority of women, with nulliparous women less likely to do so than parous women. The objective of this clinical review is to give evidence-based recommendations for the use of IUDs in nulliparous women

2017 Society of Family Planning

15. Long-Acting Reversible Contraception: Implants and Intrauterine Devices

Long-Acting Reversible Contraception: Implants and Intrauterine Devices Long-Acting Reversible Contraception: Implants and Intrauterine Devices - ACOG Menu ▼ Long-Acting Reversible Contraception: Implants and Intrauterine Devices Page Navigation ▼ Number 186, November 2017 (Replaces Practice Bulletin Number 121, July 2011) Committee on Practice Bulletins—Gynecology . This Practice Bulletin was developed by the Committee on Practice Bulletins—Gynecology and the Long-Acting Reversible (...) , incurred in connection with this publication or reliance on the information presented. Long-Acting Reversible Contraception: Implants and Intrauterine Devices Intrauterine devices and contraceptive implants, also called long-acting reversible contraceptives (LARC), are the most effective reversible contraceptive methods. The major advantage of LARC compared with other reversible contraceptive methods is that they do not require ongoing effort on the part of the patient for long-term and effective use

2017 American College of Obstetricians and Gynecologists

16. Self-Administered Lidocaine Gel for Intrauterine Device Insertion in Nulliparous Women: A Randomized Controlled Trial (Abstract)

Self-Administered Lidocaine Gel for Intrauterine Device Insertion in Nulliparous Women: A Randomized Controlled Trial To evaluate self-administration of vaginal lidocaine gel to decrease pain with intrauterine device (IUD) insertion in nulliparous women.In this randomized, double-blind, placebo-controlled trial, women self-administered 2% lidocaine or placebo vaginal gel 5 minutes before IUD insertion. The primary outcome was change in pain from baseline to IUD insertion on a 100-mm visual

2016 EvidenceUpdates Controlled trial quality: predicted high

17. New developments in intrauterine device use: focus on the US Full Text available with Trip Pro

New developments in intrauterine device use: focus on the US Many more women in the US today rely upon intrauterine devices (IUDs) than in the past. This increased utilization may have substantially contributed to the decline in the percentage of unintended pregnancies in the US. Evidence-based practices have increased the number of women who are medically eligible for IUDs and have enabled more rapid access to the methods. Many women enjoy freedom to use IUDs without cost, but for many

2016 Open access journal of contraception

18. Intrauterine devices and risk of uterine perforation: current perspectives Full Text available with Trip Pro

Intrauterine devices and risk of uterine perforation: current perspectives Uterine perforation is an uncommon complication of intrauterine device insertion, with an incidence of one in 1,000 insertions. Perforation may be complete, with the device totally in the abdominal cavity, or partial, with the device to varying degrees within the uterine wall. Some studies show a positive association between lactation and perforation, but a causal relationship has not been established. Very rarely (...) , a device may perforate into bowel or the urinary tract. Perforated intrauterine devices can generally be removed successfully at laparoscopy.

2016 Open access journal of contraception

19. Ketorolac for Pain Control With Intrauterine Device Placement: A Randomized Controlled Trial Full Text available with Trip Pro

Ketorolac for Pain Control With Intrauterine Device Placement: A Randomized Controlled Trial To evaluate intramuscular ketorolac compared with placebo saline injection for pain control with intrauterine device (IUD) placement.We conducted a randomized, double-blind, placebo-controlled trial between July 2012 and March 2014. Patients received 30 mg ketorolac or placebo saline intramuscular injection 30 minutes before IUD placement. The primary outcome was pain with IUD placement on a 10-cm

2015 EvidenceUpdates Controlled trial quality: predicted high

20. Increasing Access to Contraceptive Implants and Intrauterine Devices to Reduce Unintended Pregnancy

Increasing Access to Contraceptive Implants and Intrauterine Devices to Reduce Unintended Pregnancy Increasing Access to Contraceptive Implants and Intrauterine Devices to Reduce Unintended Pregnancy - ACOG Menu ▼ Increasing Access to Contraceptive Implants and Intrauterine Devices to Reduce Unintended Pregnancy Page Navigation ▼ Number 642, October 2015 (Replaces Committee Opinion Number 450, December 2009) (Reaffirmed 2018) Committee on Gynecologic Practice Long-Acting Reversible (...) Contraception Working Group This document reflects emerging clinical and scientific advances as of the date issued and is subject to change. The information should not be construed as dictating an exclusive course of treatment or procedure to be followed. Increasing Access to Contraceptive Implants and Intrauterine Devices to Reduce Unintended Pregnancy ABSTRACT: Unintended pregnancy persists as a major public health problem in the United States. Although lowering unintended pregnancy rates requires

2015 American College of Obstetricians and Gynecologists